Harlan Levine

With a unique perspective on healthcare policy, employer-sponsored benefits and health equity shaped by a career that spans much of the healthcare ecosystem, Harlan Levine, M.D., is a disruptor agitating for a new cancer care delivery paradigm that ensures more cancer patients have access to tomorrow’s cures today. As president of health innovation and policy at City of Hope (COH), one of the largest cancer research and treatment organizations in the U.S., and as chairman of the board for AccessHope, a spinoff company of COH that he personally devised and founded to provide access to specialized cancer care as an employer-sponsored benefit, Levine is a trailblazer in healthcare innovation with a track record of disrupting the status quo to better serve patients.